1. C. difficile infection – Can we do better?
- Author
-
John Coia
- Subjects
0301 basic medicine ,Microbiology (medical) ,medicine.medical_specialty ,Clostridioides difficile ,business.industry ,030106 microbiology ,Nosocomial pathogens ,General Medicine ,C difficile ,Europe ,03 medical and health sciences ,0302 clinical medicine ,Infectious Diseases ,Surveys and Questionnaires ,Antibiotic therapy ,Epidemiology ,Clostridium Infections ,Humans ,Medicine ,030212 general & internal medicine ,business ,Intensive care medicine ,Enterocolitis, Pseudomembranous - Abstract
C. difficile is a major nosocomial pathogen, and is also increasingly recognised as an important diarrhoeal pathogen in the community, not invariably associated with antibiotic therapy. As a result of changes in the epidemiology and clinical features of C. difficile infection (CDI), there has been a great deal of effort and activity aimed at developing and implementing comprehensive guidance for the surveillance, diagnosis, prevention, control and management of this major pathogen. While considerable progress has been made in reducing the burden of CDI, it remains a very significant infection challenge in many parts of Europe and beyond. In this theme section, we provide a series of short reviews that address some of these current issues and how they can be addressed.
- Published
- 2018
- Full Text
- View/download PDF